3 recruiting, 2 not yet recruiting, 1 unknown. 3 Phase 3, 2 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 2, Not yet recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow GnP: new trials by email Literature Review of GnP trials Research Report on GnP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of Neoadjuvant Therapy in Patients With Surgically Resectable Pancreatic Adenocarcinoma. GnP, FOLFIRINOX - Pancreatic Adenocarcinoma Resectable, Non Metastatic | Phase 2 | Not yet recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 42 | 2027-01-01 | 2026-09-15 |
| Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma Atebimetinib, GnP, mGnP - Pancreatic Cancer, Pancreatic Cancer Metastatic | Phase 3 | Recruiting | Immuneering Corporation | 510 | 2026-06-05 | 2026-10-23 |
| A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2) GnP, SBRT, Serplulimab - PDAC - Pancreatic Ductal Adenocarcinoma | Phase 3 | Not yet recruiting | West China Hospital | 198 | 2026-02-01 | 2026-01-13 |
| A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations ALTA3263, cetuximab, mFOLFOX6 - Cancer, PDAC - Pancreatic Ductal Adenocarcinoma | Phase 1 | Recruiting | Alterome Therapeutics, Inc. | 448 | 2025-03-05 | 2026-10-26 |
| Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP GS, GnP - Pancreatic Adenocarcinoma | Phase 2 / Phase 3 | Recruiting | Kochi University | 500 | 2019-01-01 | 2022-03-07 |
| The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer Chemotherapy (Gemcitabine + nab-paclitaxel) - Pancreatic Adenocarcinoma, Chemotherapy Effect | Phase 4 | Unknown | Seoul National University Hospital | 40 | 2018-03-01 | 2018-02-12 |
Pancreatic Neoplasms (3) · Neoplasm Metastasis (2) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1)
Alterome Therapeutics, Inc. (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Immuneering Corporation (1) · Kochi University (1) · Seoul National University Hospital (1) · West China Hospital (1)
United States (2) · Australia (1) · France (1) · Georgia (1) · Germany (1) · Hungary (1) · Japan (1) · Poland (1) · Romania (1) · South Korea (1) · Spain (1) · United Kingdom (1)